This study investigates the use of recurrent neural networks, commonly referred to as RNNs, in tracking the development of diabetes with the goal of revolutionizing tailored medical intervention. A deductive strategy is used, supported by a descriptive research methodology, and is based on an interpretivist theoretical framework. An RNN-based model is created and trained to identify temporal relationships in the data by utilizing secondary data sources, such as persistent records of patients, medication the pasts and aspects of lifestyle. The regression neural network (RNN) model outperforms traditional monitoring techniques in its ability to forecast long-term as well as short-term patterns in the course of diabetes. Comparative analysis demonstrates its superiority to conventional methods and demonstrates its potential to revolutionize the treatment of diabetes. The combination of several data sources, including comorbidities as well as lifestyle factors, considerably improves prediction accuracy and offers a more complex picture of how diseases develop. The model's efficiency in practical problems healthcare settings has been validated through clinical studies. Patients who use the RNN-based approach benefit from better glucose control and greater managing one's own confidence. Clinicians report improved patient outcomes and faster decision-making procedures. The significance of meticulous verification of data and comprehension is highlighted by critical analysis. The incorporation of multimodal data sources, the dynamic adaptability provided by the RNN method, and focused on patients' outcomes research are suggested as areas for further investigation. This revolutionary method of tracking the advancement of diabetes must still be advanced while taking ethical and legal factors into account.